Thyroid cancer trials in China

In China 82 Also abroad 228

53 of 82 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery
Where
Shanghai
Age
18 years and over
People
668
Run by
Xiaonan Huang
See details and how to joinNCT06931743
Phase 2Taking people
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Where
Beijing
Age
18 years and over
People
60
Run by
Beijing Scitech-Mq Pharmaceuticals Limited
See details and how to joinNCT06359847
Phase 2Taking people
MRG003 Added to Ongoing Treatment After Progression in EGFR-Positive Advanced Thyroid Cancer
Where
Guangzhou
Age
18 years to 80 years
People
39
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07874321
Phase 1/2Taking people
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Where
Beijing, Jinan, Shanghai, Suzhou
Age
18 years and over
People
554 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00
No phaseTaking people
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
Where
Shanghai
Age
18 years to 60 years
People
200
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT07707401
Early phase 1Taking people
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Where
Wuxi
Age
18 years to 75 years
People
10
Run by
FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07459283
No phaseTaking people
Safety and Efficacy of Cryoablation for Thyroid Tumors
Where
Beijing
People
108
Run by
Yukun Luo
See details and how to joinNCT07776262
Phase 2Taking people
Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer
Where
Shanghai
Age
18 years and over
People
72
Run by
Fudan University
See details and how to joinNCT07777536
No phaseTaking people
Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer
Where
Xiamen
Age
18 years to 90 years
People
120
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07753499
No phaseTaking people
Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study
Where
Guangzhou, Hangzhou
Age
18 years and over
People
85
Run by
Tian'an Jiang
See details and how to joinNCT07328243
No phaseTaking people
Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
Where
Beijing
Age
16 years to 60 years
People
108
Run by
Ming-an Yu
See details and how to joinNCT07302672
Phase 1Taking people
A Study of DEG6498 in Participants With Solid Tumors
Where
Beijing, Guangzhou
Age
18 years and over
People
100
Run by
Degron Therapeutics Co.
See details and how to joinNCT07244835
Phase 1Not yet taking people in China
Study of SNH-118110 in Advanced Solid Tumors
Where
Shanghai
Age
18 years and over
People
240
Run by
ScinnoHub Pharmaceutical Co., Ltd.
See details and how to joinNCT07649200
No phaseTaking people
Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients
Where
Tianjin
Age
18 years to 60 years
People
150
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07634978
No phaseTaking people
Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
Where
Hangzhou
Age
18 years and over
People
94
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT07068542
Phase 2/3Taking people
Trop2-targeted immunoPET Imaging of Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
400
Run by
RenJi Hospital
See details and how to joinNCT06851663
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Daping, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanjing, Shanghai, Shatin, Shenyang, Shenzhen, Taiyuan, Weifang, Wuhan, Xiamen, Xi'an, Xuzhou, Zhengzhou
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Where
Shanghai
Age
18 years and over
People
21
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06141369
Phase 3Taking people
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Where
Shanghai
Age
14 years to 80 years
People
250
Run by
Fudan University
See details and how to joinNCT06554652
Phase 3Taking people
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Where
Shanghai
Age
14 years to 80 years
People
124
Run by
Fudan University
See details and how to joinNCT06558981
Phase 1Taking people
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
Where
Beijing
Age
18 years and over
People
12
Run by
SHAOYAN LIU
See details and how to joinNCT07438847
Phase 1/2Taking people
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Where
Beijing, Chengdu, Chongqing, Fuzhou, Haikou, Heilongjiang, Henan, Hunan, Shanghai
Age
18 years to 80 years
People
54
Run by
Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07433283
Phase 3Taking people
CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
Where
Beijing
People
150
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07383246
Phase 4Not yet taking people in China
Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
Where
Chongqicun
Age
18 years to 65 years
People
114
Run by
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07354698
Phase 3Taking people
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Where
Beijing, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Gui'lin, Hainan, Hangzhou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Liuzhou, Nanchang, Nanjing, Shanghai, Shengyang, Tianjin, Ürümqi, Weifang, Wuhan, Xi'an, Xi’an, Xuzhou, Zhengzhou
Age
18 years to 75 years
People
144
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06860971